BR9305525A - Teste de anticorpos para amilina - Google Patents

Teste de anticorpos para amilina

Info

Publication number
BR9305525A
BR9305525A BR9305525A BR9305525A BR9305525A BR 9305525 A BR9305525 A BR 9305525A BR 9305525 A BR9305525 A BR 9305525A BR 9305525 A BR9305525 A BR 9305525A BR 9305525 A BR9305525 A BR 9305525A
Authority
BR
Brazil
Prior art keywords
amylin
antibody test
monoclonals
assays
binds
Prior art date
Application number
BR9305525A
Other languages
English (en)
Inventor
Julie L Phelps
Eric K Blase
Joy E Koda
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of BR9305525A publication Critical patent/BR9305525A/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9305525A 1992-05-15 1993-05-17 Teste de anticorpos para amilina BR9305525A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88375492A 1992-05-15 1992-05-15
PCT/US1993/004651 WO1993023435A1 (en) 1992-05-15 1993-05-17 Antibody assay for amylin

Publications (1)

Publication Number Publication Date
BR9305525A true BR9305525A (pt) 1995-03-01

Family

ID=25383273

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9305525A BR9305525A (pt) 1992-05-15 1993-05-17 Teste de anticorpos para amilina

Country Status (10)

Country Link
EP (1) EP0594843B1 (pt)
JP (1) JP2820797B2 (pt)
AT (1) ATE281471T1 (pt)
AU (1) AU679182B2 (pt)
BR (1) BR9305525A (pt)
CA (1) CA2113278A1 (pt)
DE (1) DE69333683T2 (pt)
ES (1) ES2232811T3 (pt)
NZ (1) NZ253449A (pt)
WO (1) WO1993023435A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000509369A (ja) * 1996-03-15 2000-07-25 アミリン・ファーマシューティカルズ・インコーポレイテッド グリコシル化アミリン類
AUPP349098A0 (en) * 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
AU631112B2 (en) * 1988-01-11 1992-11-19 Amylin Corporation Treatment of type 2 diabetes mellitus
AU620727B2 (en) * 1989-07-10 1992-02-20 Amylin Pharmaceuticals, Inc. Treatment of obesity and essential hypertension and related disorders
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
DE69221040T2 (de) * 1991-01-10 1997-11-13 Amylin Pharmaceuticals Inc Aktivätsmessungen des amylin

Also Published As

Publication number Publication date
NZ253449A (en) 1994-12-22
AU679182B2 (en) 1997-06-26
DE69333683T2 (de) 2005-10-27
ES2232811T3 (es) 2005-06-01
JPH07508173A (ja) 1995-09-14
JP2820797B2 (ja) 1998-11-05
CA2113278A1 (en) 1993-11-25
EP0594843B1 (en) 2004-11-03
EP0594843A1 (en) 1994-05-04
AU4377993A (en) 1993-12-13
WO1993023435A1 (en) 1993-11-25
DE69333683D1 (de) 2004-12-09
ATE281471T1 (de) 2004-11-15

Similar Documents

Publication Publication Date Title
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
DE59010787D1 (de) Erythropoietin (EPO)-Peptide und dagegen gerichtete Antikörper
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
DE69417417D1 (de) Monoklonale antikörper gegen den alpha-pdgf-rezeptor und deren verwendungen
DE69532889D1 (de) Interleukin-5-spezifische rekombinante antikörper
DK0482176T3 (da) Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficile
PT827512E (pt) Anticorpo especifico para staphylococcus aureus e sua utilizacao
DE69233125D1 (de) Inhibitorische immunglobulin-polypeptide gegen den pdgf beta-rezeptor
ES551494A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivos con antigenos de esporozoitos o merozoitos de eimeria spp.
TW222686B (pt)
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
PT1078266E (pt) Dosagem imunologica da cromogranina a humana (cga), anticorpos, reagentes e conjuntos utilizaveis para essa dosagem
DK327289A (da) Diagnostiske metoder og systemer til kvantificering af apo ai
BR9305525A (pt) Teste de anticorpos para amilina
ES2061664T3 (es) Anticuerpos monoclonales que reconocen a alfa-hanp y correspondientes hibridomas, su preparacion y uso.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
NO974852L (no) Humant <beta>2-integrin-<alfa>-subenhet
ES2019573T3 (es) Inmunoensayo para la deteccion de alfa-haloacetamidas.
DE69020315T2 (de) Monoklonaler antikörper gegen c-reaktives protein.
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.
GT199500014A (es) Inmunoensayo para tetracloroisoftalonitrilo (clonotalonilo (mr)), sus derivados y productos de descomposicion
DK0574461T3 (da) Humaniserede, monoklonale højaffinitetsantistoffer
FI102217B1 (fi) Menetelmä Pseudomonas aeruginosa-serotyyppien toteamiseksi näytteestä in vitro monoklonaalisten vasta-aineiden avulla, menetelmässä käytettäviä monoklonaalisia vasta-aineita sekä menetelmässä käyttökelpoinen testipakkaus
HU9300054D0 (en) Developing elisa test based on monoclonal antibodies to detect infection by m. gallisepticum
ES2059726T3 (es) Anticuerpos monoclonales que reconocen el itsp humano, hibridomas que producen los mismos, y su preparacion y uso.

Legal Events

Date Code Title Description
EE Request for examination
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law